Ghost Tree Capital »

Helix Acquisition Corp Ii Cl A shares owned by Ghost Tree Capital

Quarter-by-quarter ownership of Helix Acquisition Corp Ii Cl A (HLXB) shares owned by Ghost Tree Capital from 13F filings

Historical chart of Ghost Tree Capital investment in Helix Acquisition Corp Ii Cl A

Tip: Access up to 7 years of quarterly data

All positions including Helix Acquisition Corp Ii Cl A held by Ghost Tree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Helix Acquisition Corp Ii Cl A by Ghost Tree Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.1M 300k 10.22
2024-03-31 $3.1M 300k 10.40

More positions owned by Ghost Tree Capital

Alnylam Pharmaceuticals (ALNY)
Insmed Com Par $.01 (INSM)
Biohaven (BHVN)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Soleno Therapeutics (SLNO)
Axsome Therapeutics (AXSM)
Ascendis Pharma A/s Sponsored Adr (ASND)
Vaxcyte (PCVX)
Crinetics Pharmaceuticals In (CRNX)
Roivant Sciences SHS (ROIV)
Perspective Therapeutics Com New (CATX)
Tg Therapeutics (TGTX)
Sarepta Therapeutics (SRPT)
Cg Oncology (CGON)
Corbus Pharmaceuticals Hldgs Com New (CRBP)

View all positions for Ghost Tree Capital

Top funds holding Helix Acquisition Corp Ii Cl A

Cormorant Asset Management
BlackRock
Citadel Advisors
T. Rowe Price Associates
Millennium Management
OZ Management
Farallon Capital Management
Dr. Jeffrey R. Jay, M.D.
Silverarc Capital Management
Perceptive Advisors
Commodore Capital
Soros Fund Management
T. Rowe Price Investment Management
Laurion Capital Management
Ghost Tree Capital

View all funds holding Helix Acquisition Corp Ii Cl A